Purinergic P2X 7 receptors participate in disturbed intracellular calcium homeostasis in peripheral blood mononuclear cells of patients with chronic kidney disease

Kidney and Blood Pressure Research

Volumn 35, Issue 1, 2012, Pages 48-57

  Lajdova, Ingrid ^a   Oksa, Adrian ^a   Chorvat Jr , Dusan ^b   Topor, Peter ^b   Spustova, Viera ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b INTERNATIONAL LASER CENTER   (Slovakia)

Author keywords

Chronic kidney disease; Human lymphocytes; Intracellular calcium; P2X 7 receptors

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; CALCIUM ION; ETHIDIUM BROMIDE; PURINERGIC P2X7 RECEPTOR; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; DRUG DERIVATIVE;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL PERMEABILIZATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOSOL; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POROSITY; PRIORITY JOURNAL; CHRONIC KIDNEY FAILURE; DRUG EFFECT; FEMALE; HOMEOSTASIS; INTRACELLULAR FLUID; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADENOSINE TRIPHOSPHATE; ADULT; CALCIUM SIGNALING; FEMALE; HOMEOSTASIS; HUMANS; INTRACELLULAR FLUID; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECEPTORS, PURINERGIC P2X7; RENAL INSUFFICIENCY, CHRONIC;

EID: 80051794384     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000330349     Document Type: Article

References (36)

1. Putney JW Jr, Broad LM, Braun FJ, Lievremont JP, Bird GS: Mechanisms of capacitative calcium entry. J Cell Sci 2001; 114: 2223-2229.
2. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-492.
3. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR: Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587-600.
4. Erik M, Schwiebert EM, Kishore BK: Extracellular nucleotide signaling along the renal epithelium. Am J Physiol Renal Physiol 2001; 280:F945-F963.
5. Hillman KA, Burnstok G, Unwin RJ: The P2X 7 ATP receptor in the kidney: a matter of life or death? Nephron Exp Nephrol 2005; 101: 24-30.
6. North AR: Molecular physiology of P2X receptors. Physiol Rev 2002; 82: 1013-1067.
7. Wiley JS, Chen JR, Jamieson GP: The ATP4 -receptor-operated channel (P2Z class) of human lymphocytes allows Ba 2+ and ethidium + uptake: inhibition of fluxes by suramin. Arch Biochem Biophys 1993; 305: 54-60.
8. Massry SG, Fadda GZ: Chronic renal failure is a state of cellular calcium toxicity. Am J Kidney Dis 1993; 21: 81-86.
9. Ori Y, Korzets T, Malachi U, Gafter U, Breitbart H: Impaired lymphocyte calcium metabolism in end-stage renal disease: enhanced influx, decreased efflux, and reduced response to mitogen. J Lab Clin Med 1999; 133: 391-400.
10. Lajdova I, Spustova V, Oksa A, Chorvatova A, Chorvat D Jr, Dzurik R: Intracellular calcium homeostasis in patients with early stages of chronic kidney disease: effects of vitamin D 3 supplementation. Nephrol Dial Transplant 2009; 24: 3376-3381.
11. K/DOQI: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(suppl 3):S1-S201.
12. Levey AS, Coresh J, Greene T, Stevents LA, Zhang YL, Hendriksen S, Kusek JW, Van Lentle F: Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
13. Lajdova I, Chorvat D Jr, Chorvatova A: Rapid effects of 1 α,25(OH) 2 D 3 in resting human peripheral blood mononuclear cells. Eur J Pharmacol 2008; 586: 14-23.
14. Lajdova I, Chorvat D Jr, Spustova V, Chorvatova A: 4-Aminopyridine activates calcium influx through modulation of the poreforming purinergic receptor in human peripheral blood mononuclear cells. Can J Physiol Pharmacol 2004; 82: 50-56.
15. Tsien RY: Fluorescence measurement and photochemical manipulation of cytosolic free calcium. Trends Neurochem Sci 1998; 11: 419-423.
16. Hoth M, Penner R: Depletion of intracellular calcium stores activate a calcium current in mast cells. Nature 1992; 355: 353-356.
17. Kao JP: Practical aspects of measuring [Ca 2+ ] with fluorescent indicators. Methods Cell Biol 1994; 40: 155-181.
18. Bootman MD, Collins TJ, Mackenzie L, Roderick HL, Berridge MJ, Peppiat CM: 2-Aminoethoxydiphenyl borate (2APB) is reliable blocker of store-operated Ca 2+ entry but an inconsistent inhibitor of InsP 3 -induced Ca 2+ release. FASEB J 2002; 16: 1145-1150.
19. Lister FM, Sharkey J, Sawatzky DA, Hodgkiss JP, Davidson DJ, Rossi AG, Finlayson K: The role of the purinergic P2X 7 receptor in inflammation. J Inflamm 2007; 4: 5.
20. Al-Shukaili A, Al-Kaabi J, Hassan B: A Comparative study of interleukin-1 βproduction and P2X 7 expression after Atp stimulation by peripheral blood mononuclear cells isolated from rheumatoid arthritis patients and normal healthy controls. Inflammation 2008; 31: 84-90.
21. Skaper DS, Debetto P, Giusti P: The P2X 7 purinergic receptor: from physiology to neurological disorders. FASEB J 2010; 24: 337-345.
22. Ralevic V, Burnstock G: Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 2003; 3: 133-140.
23. Turner CM, Tam FWK, Lai P, Tarzi RM, Burnstock G, Pusey CD, Cook HT, Unwin RJ: Increased expression of pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis. Nephrol Dial Transplant 2007; 22: 386-395.
24. Taylor SRJ, Turner CM, Elliot JI, McDaid J, Hewitt R, Smith J, Pickering MC, Whitehouse DL, Cook HT, Burnstock G, Pusey CD, Unwin RJ, Tam FWK: P2X 7 deficiency attenuates renal injury in experimental glomerulonephritis. J Am Soc Nephrol 2009; 20: 1275-1281.
25. Gafter U, Malachi T, Barak H, Djaldetti M, Levi J: Red blood cell calcium homeostasis in patients with end-stage renal disease. J Lab Clin Med 1989; 114: 221-231.
26. Polak-Jonkisz D, Zwolinska D, Purzyc L, Musial K: Ca 2+ -Mg 2+ -dependent ATPase activity and calcium homeostasis in children with chronic kidney disease. Pediatr Nephrol 2007; 22: 414-419.
27. Bautista DM, Lewis RS: Modulation of plasma membrane calcium-ATPase activity by local calcium microdomains near CRAC channels in human T cells. J Physiol 2004; 556: 805-817.
28. Sluyter R, Barden JA, Wiley JS: Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 2001; 304: 231-236.
29. Gargett CE, Cornish JE, Wiley JS: ATP, a partial agonist for the P2Z receptor of human lymphocytes. Br J Pharmacol 1997; 122: 911-917.
30. Gargett CE, Wiley J: The isoquinoline derivate KN-62: a potent antagonist of the P2Z receptor of human lymphocytes. Br J Pharmacol 1997; 120: 1483-1490.
31. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F: The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006; 176: 3877-3883.
32. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G: The cytosolic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996; 272: 735-738.
33. Cabrini G, Flazoni S, Forchap SI, Pellegatti P, Balboni A, Agostini P, Cuneo A, Castoldi G, Baricordi OR, Di Virgilio F: A His-155 to Tyr polymorphism confers gain-of-function to the human P2X 7 receptor of human leukemic lymphocytes. J Immunol 2005; 175: 82-89.
34. Wiley JS, Dao-Ung LP, Gu BJ, Sluyter R, Shemon AN, Li C, Taper J, Gallo J, Manoharan A: A loss-function polymorphic mutation in the cytolytic P2X 7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002; 359: 1114-1119.
35. Sluyter R, Shemon AN, Wiley JS: Glu-296 to Ala polymorphism in the P2X 7 receptor impairs ATP-induced IL-1 βrelease from human monocytes. J Immunol 2004; 172: 3399-3405.
36. Franco-Martinez S, Nino-Moreno P, Bernal-Silva S, Baranda L, Rocha-Meza M, Portales-Cervantes L, Layseca-Espinosa E, Gonzalez-Amaro R, Portales-Perez D: Expression and function of the purinergic receptor P2X 7 in patients with pulmonary tuberculosis. Clin Exp Immunol 2006; 146: 253-261.